Itamar Medical (Israel) Management Performance Evaluation

ITMR -- Israel Stock  

ILS 122.70  1.40  1.15%

Analysis of Itamar Medical manpower and management performance can provide insight into Itamar Medical stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Itamar Medical future performance. Itamar Medical employes about 16 people. The company is managed by 27 executives with total tenure of roughly 190 years, averanging almost 7.0 years of service per executive having 1.0 employee per reported executive. Please also check Risk vs Return Analysis.
  Gilad Glick  CEO
CEO and Pres
  Martin Gerstel  Chairman
Co-Chairman, Bus. Advisor, Member of Executive Committee and Member of Investment Committee
  Giora Yaron  Chairman
Co-Chairman, Bus. Advisor and Member of Executive Committee

Itamar Medical Management Effectiveness

The company has return on total asset (ROA) of (9.84) % which means that it has lost $9.84 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (42.88) % meaning that it generated substantial loss on money invested by shareholders.

Itamar Medical Workforce Comparison

Itamar Medical Ltd is rated third overall in number of employees category among related companies. The total workforce of Medical Devices industry is currently estimated at about 52.0. Itamar Medical totals roughly 16.0 in number of employees claiming about 31% of all equities under Medical Devices industry.

Itamar Medical Profit Margins

The company has Profit Margin (PM) of (7.15) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (12.9) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.13.

Itamar Medical Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of thirty-nine. Itamar Medical Price Series Summation is a cross summation of Itamar Medical price series and its benchmark/peer. View also all equity analysis or get more info about price series summation math operators indicator.

Itamar Medical Stakeholders

Gilad Glick CEO and Pres
Martin Gerstel Co-Chairman, Bus. Advisor, Member of Executive Committee and Member of Investment Committee
Giora Yaron Co-Chairman, Bus. Advisor and Member of Executive Committee
Ira Prigat VP and President of Itamar Medical Japan
Arnon Tuval Vice President of Operations - Itamar Medical Inc.
Joseph Tenne Vice President - Finance
Shlomo Ayanot Vice President of Operations & Engineering
Christopher Hallett Vice President of Sales - Itamar Medical Inc. - North American
Shay Basson Vice President - Finance
Efrat Litman Vice President - Research & Development
Shaul Sharoni CFO and Sr. VP
Jacob Sheffy CTO and Executive VP
Miri Katz External Director
Jonathan Kolber Director
Christopher Cleary Director
Maya TalPachter Director, Global Marketing
Shmuel Blumenfeld Director
Zipora OzerArmon External Director
Steven Ruchefsky Director
Gary Ellis Director
Sami Totah Director
Yaffa Sieradzki External Director
Yair Orgler External Director
Dafna Katz VP of Global Marketing
Eldad Singer VP of Sales Research
Daphna Triwaks Head of PR
Shahar Cohen Controller

Itamar Medical Manpower Efficiency

Return on Itamar Medical Manpower

Revenue Per Employee1.5 M
Revenue Per Executive895.9 K
Net Loss Per Employee108.1 K
Net Loss Per Executive64.1 K
Working Capital Per Employee1.8 M
Working Capital Per Executive1 M
Please also check Risk vs Return Analysis. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.
Search macroaxis.com